The year in valvular heart disease.
Rahimtoola
Shahbudin H
SH
Division of Cardiovascular Medicine, Department of Medicine, LAC+USC Medical Center, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.
D000818:Animals; D019072:Antibiotic Prophylaxis; D000925:Anticoagulants / Q000008:administration & dosage; D001022:Aortic Valve Insufficiency / Q000628:therapy; D001024:Aortic Valve Stenosis / Q000188:drug therapy / Q000503:physiopathology; D001705:Bioprosthesis; D002114:Calcinosis / Q000473:pathology; D017147:Defibrillators, Implantable; D015150:Echocardiography, Doppler; D004691:Endarterectomy; D004697:Endocarditis, Bacterial / Q000517:prevention & control; D005260:Female; D006349:Heart Valve Diseases / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D006350:Heart Valve Prosthesis; D006351:Heart Valves / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D007150:Immunohistochemistry; D008279:Magnetic Resonance Imaging; D008943:Mitral Valve / Q000473:pathology; D008944:Mitral Valve Insufficiency / Q000503:physiopathology; D008946:Mitral Valve Stenosis / Q000503:physiopathology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular; D011651:Pulmonary Artery / Q000601:surgery; D014262:Tricuspid Valve Insufficiency / Q000517:prevention & control; D016277:Ventricular Function, Left; D014859:Warfarin / Q000008:administration & dosage
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin